share_log

Carisma Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-AbbVie Biotechnology Ltd.(6.8%)

SEC ·  Mar 14, 2024 04:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more